Date posted: 3/11/2020

Towards zero

Help the National Breast Cancer Foundation reach its goal of zero deaths from breast cancer by 2030.

The National Breast Cancer Foundation is shining a light on the 9% of Australian women with breast cancer who don’t reach the five-year survival mark.

The Foundation’s mission of zero deaths from breast cancer by 2030 hopes to see the 91% survival rate reach 100% by funding world-class research, including projects targeting treatment resistant breast cancer, metastatic and triple negative breast cancer.

The facts are:

  • 9% of Australia women diagnosed with breast cancer don’t survive five years
  • In the next 10 years, 30,000 lives could be lost to breast cancer without adequate research funding. More than half of the 30,000 lives will be within five years of diagnosis.

Chartered Accountants Australia and New Zealand has been in partnership with the National Breast Cancer Foundation for 10 years in the community care program entitled Everybody Counts. 

Our partnership has been both rewarding and beneficial, with one of the major fundraisers in New South Wales being the annual Charity Event in Sydney, which has been running since 2012.

Normally, we would be gearing up to come together for this event, but this year things are very different.

Having raised more than A$150,000 since the start of this annual fundraiser, we are excited and look forward to resuming this event in 2021.

How you can help

Uncovering new treatments for metastatic triple negative breast cancer, and mapping the cell atlas of breast cancer.

NBCF has been running the Towards Zero webinar series as a way to keep us all connected during this time.

We thought it would be a great opportunity to offer an update from NBCF-funded researcher Associate Professor Alex Swarbrick, who we heard from at our event in Sydney last year.

Associate Prof Swarbrick will talk about new treatment alternatives for metastatic triple negative breast cancer and will share updates on a world-first breast cancer cell atlas, that and his team have developed.

You will learn:

  • How cutting-edge technologies are used to study the genetics of cancer cells of women with triple negative breast cancer.
  • About the complex cellular ‘ecosystem’ of breast cancers.
  • About potential treatment options, with a particular focus on immunotherapy drug targets.

Webinar details:

  • Wednesday, 18 November 2020
  • Time: 3 – 3.30pm (AEDT)
  • Price: Free

More information

For more information, updates and to support the National Breast Cancer Foundation, visit their website below. 

Search related topics